Insufficient scRNA-seq data for expression of SLC7A10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 91% | 882.90 | 2415 / 2642 | 43% | 4.44 | 306 / 705 |
adipose | 96% | 2677.60 | 1156 / 1204 | 0% | 0 | 0 / 0 |
breast | 71% | 1569.11 | 326 / 459 | 23% | 0.81 | 255 / 1118 |
thymus | 22% | 45.01 | 146 / 653 | 16% | 0.52 | 96 / 605 |
ovary | 0% | 0 | 0 / 180 | 28% | 1.39 | 121 / 430 |
lung | 0% | 0 | 0 / 578 | 23% | 2.02 | 270 / 1155 |
bladder | 10% | 23.29 | 2 / 21 | 12% | 0.37 | 62 / 504 |
kidney | 11% | 57.24 | 10 / 89 | 4% | 0.17 | 36 / 901 |
uterus | 0% | 0 | 0 / 170 | 14% | 2.66 | 65 / 459 |
liver | 0% | 0 | 0 / 226 | 13% | 2.59 | 52 / 406 |
eye | 0% | 0 | 0 / 0 | 13% | 0.20 | 10 / 80 |
stomach | 2% | 11.26 | 6 / 359 | 10% | 1.11 | 29 / 286 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.64 | 3 / 29 |
esophagus | 2% | 11.61 | 36 / 1445 | 8% | 0.79 | 14 / 183 |
pancreas | 1% | 1.35 | 3 / 328 | 9% | 0.31 | 16 / 178 |
skin | 3% | 8.50 | 49 / 1809 | 7% | 0.51 | 33 / 472 |
adrenal gland | 7% | 27.20 | 19 / 258 | 1% | 0.05 | 3 / 230 |
blood vessel | 8% | 44.73 | 112 / 1335 | 0% | 0 | 0 / 0 |
intestine | 3% | 17.83 | 29 / 966 | 5% | 0.55 | 25 / 527 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.21 | 3 / 45 |
heart | 2% | 5.96 | 20 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 3.89 | 14 / 803 | 0% | 0 | 0 / 0 |
prostate | 0% | 2.85 | 1 / 245 | 0% | 0.01 | 2 / 502 |
peripheral blood | 1% | 1.11 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015825 | Biological process | L-serine transport |
GO_0060094 | Biological process | positive regulation of synaptic transmission, glycinergic |
GO_0006865 | Biological process | amino acid transport |
GO_0015804 | Biological process | neutral amino acid transport |
GO_1903444 | Biological process | negative regulation of brown fat cell differentiation |
GO_0042942 | Biological process | D-serine transmembrane transport |
GO_0042941 | Biological process | D-alanine transmembrane transport |
GO_0015816 | Biological process | glycine transport |
GO_0003333 | Biological process | amino acid transmembrane transport |
GO_1902475 | Biological process | L-alpha-amino acid transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0015175 | Molecular function | neutral L-amino acid transmembrane transporter activity |
GO_0015179 | Molecular function | L-amino acid transmembrane transporter activity |
GO_0015194 | Molecular function | L-serine transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC7A10 |
Protein name | Asc-type amino acid transporter 1 (Asc-1) (Solute carrier family 7 member 10) Solute carrier family 7 member 10 |
Synonyms | ASC1 |
Description | FUNCTION: Associates with SLC3A2/4F2hc to form a functional heterodimeric complex that translocates small neutral L- and D-amino acids across the plasma membrane. Preferentially mediates exchange transport, but can also operate via facilitated diffusion (By similarity) . Acts as a major transporter for glycine, L- and D-serine in the central nervous system. At the spinal cord and brainstem regulates glycine metabolism and glycinergic inhibitory neurotransmission by providing for glycine de novo synthesis from L-serine and glycine recycling from astrocytes to glycinergic motor neurons (By similarity). At Schaffer collateral-CA1 synapses mediates D-serine and glycine release that modulates post-synaptic activation of NMDA receptors and excitatory glutamatergic transmission (By similarity). May regulate D-serine release from mesenchymal progenitors located in developing subcutaneous adipose tissue, favoring white adipocyte over thermogenic beige adipocyte lineage commitment (By similarity). . |
Accessions | ENST00000590036.5 ENST00000592596.1 K7EK24 ENST00000253188.8 K7ENB6 ENST00000587064.5 Q9NS82 |